ResearcherThe University of TokyoActive in the last 2 years
Kei Takahashi
Matched on ORCID iD 0000-0002-7925-6636; OpenAlex author ID A5100614592. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- In vitro functional analysis of lysyl oxidase family members in highly metastatic pancreatic cancer cells derived from a syngeneic orthotopic model. Co-author DOI 10.1186/s12885-026-16173-1↗
- Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Co-author DOI 10.1002/1878-0261.12815↗
- Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. Co-author DOI 10.1038/s41388-018-0144-0↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kohei Miyazono · 3 shared papers, 2018–2026 · strength 0.54
- Paper In vitro functional analysis of lysyl oxidase family members in highly metastatic pancreatic cancer cells derived from … DOI 10.1186/s12885-026-16173-1↗
- Paper Neurotensin receptor 1 signaling promotes pancreatic cancer progression. DOI 10.1002/1878-0261.12815↗
- Paper Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. DOI 10.1038/s41388-018-0144-0↗
- Shogo Ehata · 3 shared papers, 2018–2026 · strength 0.54
- Paper In vitro functional analysis of lysyl oxidase family members in highly metastatic pancreatic cancer cells derived from … DOI 10.1186/s12885-026-16173-1↗
- Paper Neurotensin receptor 1 signaling promotes pancreatic cancer progression. DOI 10.1002/1878-0261.12815↗
- Paper Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. DOI 10.1038/s41388-018-0144-0↗
- Manabu Kawai · 1 shared paper, 2026 · strength 0.29
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.